期刊文献+

去甲斑蝥素增强IL-15活化的PBMC对白血病KG1a细胞的杀伤作用

Norcantharidin enhances cytotoxicity of IL-15 activated PBMCs on leukemic KG1a cells
下载PDF
导出
摘要 目的:探讨去甲斑蝥素(norcantharidin,NCTD)是否能增强IL-15活化的人外周血单个核细胞(peripheral blood mononuclear cell,PBMC)对人急性髓系白血病KG1a细胞的杀伤作用及其可能机制。方法:锥虫蓝拒染法、CCK-8法检测NCTD对KG1a细胞增殖的影响,流式细胞术检测NCTD对KG1a细胞周期的影响,LDH释放法检测IL-15活化的PBMC(IL-15-PBMC)对NCTD处理后KG1a细胞的细胞毒活性,流式细胞术检测KG1a细胞表面NKG2D(natural killer group 2 member D)配体的表达。结果:NCTD有效抑制白血病KG1a细胞的增殖,呈时间(r=0.398,P=0.000)和剂量依赖性(r=0.861,P=0.000),并阻滞KG1a细胞周期于G2/M期;4μg/ml以下的NCTD对IL-15-PBMC没有明显的增殖抑制作用(P>0.05)。当效靶比为10∶1和20∶1时,IL-15-PBMC对0.125μg/ml NCTD处理后KG1a细胞的杀伤率较对照组明显增加[志愿者A:(37.44±5.78)%vs(9.33±1.69)%,(38.33±3.07)%vs(16.75±1.20)%;P<0.05]。NCTD不影响KG1a细胞表面NKG2D配体蛋白的表达(P>0.05)。结论:NCTD能增强IL-15-PBMC对白血病KG1a细胞的杀伤作用,可能与抑制细胞增殖、阻滞细胞周期于G2/M期有关。 Objective: To explore whether norcantharidin (NCTD) can enhance the cytotoxicity of IL-15 activated peripheral blood mononuclear cells (PBMCs) on human acute myeloblastic leukemic KG1a cells and its underlying mechanism. Methods: The effect of NCTD on the proliferation of KG1a cells was detected by typan blue assay and CCK-8 assay. The effect of NCTD on the cell cycle of KG1a cells was examined by flow cytometry. The cytotoxicity of IL-15 activated PBMCs (IL-15-PBMCs) against NCTD treated-KG1a cells was detected by LDH releasing assay. The expressions of NKG2D (natural killer group 2 member D) ligands on KG1a cells were detected by flow cytometry. Results: NCTD effectively inhibited the proliferation of leukemic KG1a cells, in a time- (r=0.398,P=0.000) and dose-dependent manner (r=0.861,P=0.000), and arrested KG1a cell cycle at G2/M phase. NCTD within a concentration of 4.00 μg/ml has no obvious cytotoxicity on the IL-15 activated PBMCs (IL-15-PBMCs) (P〉0.05). Compared with the control group, the cytotoxic rate of IL-15-PBMCs on 0.125 μg/ml NCTD treated-KG1a cells was significantly increased (donor A: /[37.44±5.78/]% vs /[9.33±1.69/]%, /[38.33±3.07/]% vs /[16.75±1.20/]%, P〈0.05). NCTD treatment showed no effect on expressions level of NKG2D ligands on KG1a cell surface (P〉0.05). Conclusion: NCTD can enhance the cytotoxicity of IL-15-PBMCs on leukemic KG1a cells, which is possibly related to the inhibition of proliferation of KG1a cells and cell cycle arrest in G2/M phase.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第5期580-585,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.30973454) 教育部新世纪优秀人才支持计划资助项目(No.NCET-09-0087)~~
关键词 去甲斑蝥素 白血病 KG1a细胞 IL-15 外周血单个核细胞 NKG2D配体 norcantharidin leukemia KG1a cell IL-15 peripheral blood mononuclear cell NKG2D ligand
  • 相关文献

参考文献3

二级参考文献20

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部